about
Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolismTransient GFER knockdown in vivo impairs liver regeneration after partial hepatectomyThe effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines.Vitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines.Functional foods: salient features and clinical applications.Nutritional factors and polyamine metabolism in colorectal cancer.Pharmacological and dietary agents for colorectal cancer chemoprevention: effects on polyamine metabolism (review).Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.Hydroxytyrosol Inhibits Cannabinoid CB1 Receptor Gene Expression in 3T3-L1 Preadipocyte Cell Line.Inhibitory effect of vitamin K1 on growth and polyamine biosynthesis of human gastric and colon carcinoma cell lines.Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis.Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells.Epidermal growth factor and 17beta-estradiol effects on proliferation of a human gastric cancer cell line (AGS).Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation.Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers.Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy.Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy.The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa.Mitochondria and redox balance in celiac disease: a case control study.Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats.EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet.[Calculi and sludge in the gallbladder during pregnancy]Gastric Activity and Gut Peptides in Patients With Functional Dyspepsia: Postprandial Distress Syndrome Versus Epigastric Pain Syndrome.Lipidomic analysis of fatty acids in erythrocytes of coeliac patients before and after a gluten-free diet intervention: a comparison with healthy subjectsGG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced EnteropathyNoninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control studyAdipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBSLactobacillus reuteri Strain Combination In Helicobacter pylori InfectionChanges in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infectionPolyamine biosynthesis in relation to K‐ras and p‐53 mutations in colorectal carcinomaLow presence of p53 abnormalities in H. pylori -infected gastric mucosa and in gastric adenocarcinomaThe Influence ofHelicobacter pyloriEradication on the Gastric Mucosal Content of Epidermal Growth Factor, Transforming Growth Factor-a, and Their Common ReceptorPolyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinomaDemonstration of Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma by Enzyme Immunoassay
P50
Q26825488-E77DD7B1-D8C7-497A-AA56-01B7FBDE4A7FQ28580774-9A94474B-EBA6-4E15-BA7B-4B3ECE81C411Q34573812-D8FD3E67-20AD-461F-969F-8425558DCB3BQ35086617-7F8161DE-FB7D-428D-BDE6-9EDEC47CDF81Q35667854-CE718295-6CF1-4C15-9E15-0F696D612EB5Q36264779-E31EC3D8-1ABA-465E-88E5-B8B35CD286E9Q37080655-8C87505C-1535-43A7-8385-D75CBCC045D6Q38239601-C010884D-74B1-4A43-A5EF-9D12ED3B7497Q38781874-4611995C-9B20-4F71-853B-95A52BC1A392Q38851476-AD95FA7D-7755-47EC-A5F4-609AB6B7F114Q38867487-EC96EFC3-2D15-46F2-AF97-6194D69A36F1Q39260465-BC4467EE-E0AD-4BFD-8CD8-A9341FBD26A3Q39644631-E06D62EC-254B-48A9-A688-50680F4C3150Q39715379-4FCF11B0-9D72-4F8A-BD61-0B0E0F2FB9C0Q39880897-4473111D-C47D-42F7-9688-53F57CF66FE8Q40350340-A057F0F0-5EDE-4D29-B112-CCE4FC79DBF3Q40387047-F13BE0AB-873B-4317-B321-D25510222367Q40857121-040229C5-4BDC-4D7C-9F6B-F89AAD427B3DQ42730653-8D21EB1F-B0F0-4FFF-93FC-8B16A1F240DDQ44173620-560C2595-2C8A-4118-A1B2-4BCE9A772F66Q44299622-526497A5-153D-4A20-8419-9DF54EC552ADQ44424325-21F0A167-4CB9-4D65-9512-61508E9AA873Q44833263-B5ECCD0F-EBC2-458D-AACB-D856C7BCDEA5Q46240607-D37A1254-B4BC-4045-A333-4F02B60E18ACQ46795839-CFC668A7-CC12-4C00-9FE8-62B43217E608Q47793744-E943B918-FC6E-4EF2-946F-9A5639A8610BQ47877390-F7C01A90-76B3-49CE-ACD8-0A59F68D39EFQ50189284-F26E9F07-13A3-4914-B59F-249582B39182Q50907308-9CB04D04-C589-46B1-9157-78164E632798Q56971891-DAC86883-F4D8-4DFE-8D2E-42DEB6C270C8Q58600368-05F63ED2-77CF-46C6-BFB8-8D083AB5C0F1Q58605352-A0F88F7F-33B0-4004-B4F6-6848A0226655Q60931335-FC2F2D1D-52C2-494E-B4E7-4AFCB1482B32Q62803733-F2037C93-66A9-4D26-9CE0-14F86A549A89Q62804821-BE1EF434-343D-4FAE-B9CD-2D2803FEC557Q62804965-07C9C51D-41EE-4EB7-8B09-AD1B0CCC842DQ62805081-7CB313CC-A3A9-454D-B7EC-A1ED25390069Q62805496-5CB59B57-3D60-4348-B49C-501E4C4C7ED3Q62805538-4BD12B9D-D461-4E8A-92DA-83F7CC5DF2EDQ62805656-81DBEF7C-D5B5-4793-A62A-E5D4B9F40B87
P50
description
Forscher
@de
Italian medical researcher
@en
chercheur
@fr
investigador
@es
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Francesco Russo
@en
Russo F
@ast
Russo F
@es
Russo F
@nl
type
label
Francesco Russo
@en
Russo F
@ast
Russo F
@es
Russo F
@nl
altLabel
Russo F
@en
prefLabel
Francesco Russo
@en
Russo F
@ast
Russo F
@es
Russo F
@nl
P106
P31
P496
0000-0003-0538-6072